Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04356729
Title A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Elizabeth Buchbinder
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02115 United States Details
Massachusetts General Hospital NOT_YET_RECRUITING Boston Massachusetts 02214 United States Details
Beth Israel Deaconess Medical Center NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field